Altium Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $2.02M | Sell |
|
|||||
|
2024
Q2 | $5.06M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $5.02M | Hold |
|
|||||
|
2023
Q2 | $4.49M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $2.47M | Hold |
|
|||||
|
2021
Q3 | $2.49M | Hold |
|
|||||
|
2021
Q2 | $2.59M | Hold |
|
|||||
|
2021
Q1 | $2.55M | Hold |
|
|||||
|
2020
Q4 | $2.84M | Buy |
|